The DOI matches its Crossref record; 145 of the 167 references it cites were found in a registry or an index.
Repair of O6-alkylguanine by alkyltransferases
Abstract
The predominant pathway for the repair of O(6)-methylguanine in DNA is via the activity of an alkyltransferase protein that transfers the methyl group to a cysteine acceptor site on the protein itself. This review article describes recent studies on this alkyltransferase. The protein repairs not only methyl groups but also 2-chloroethyl-, benzyl- and pyridyloxobutyl-adducts. It acts on double-stranded DNA by flipping the O(6)-guanine adduct out of the DNA helix and into a binding pocket. The free base, O(6)-benzylguanine, is able to bind in this pocket and react with the cysteine, rendering it an effective inactivator of mammalian alkyltransferases. The alkylated form of the protein is rapidly degraded by the ubiquitin/proteasomal system. Some tumor cells do not express alkyltransferase despite having an intact gene. Methylation of key sites in CpG-rich islands in the promoter region are involved in this silencing and a change in the nuclear localization of an enhancer binding protein may also contribute. The alkyltransferase promoter contains Sp1, GRE and AP-1 sites and is slightly inducible by glucocorticoids and protein kinase C activators. There is a complex relationship between p53 and alkyltransferase expression with p53 mediating a rise in alkyltransferase in response to ionizing radiation but having no clear effect on basal levels. DNA adducts at the O(6)-position of guanine are a major factor in the carcinogenic, mutagenic, apoptopic and clastogenic actions of methylating agents and chloroethylating agents. Studies with transgenic mice in which alkyltransferase levels are increased or decreased confirm the importance of this repair pathway in protecting against carcinogenesis. Alkyltransferase activity in tumors protects them from therapeutic agents such as temozolomide and BCNU. This resistance is abolished by O(6)-benzylguanine and this drug is currently in clinical trials to enhance cancer chemotherapy by these agents. Studies are in progress to reduce the toxicity of such therapy towards the bone marrow by gene therapy to express alkyltransferases with mutations imparting resistance to O(6)-benzylguanine at high levels in marrow stem cells. Several polymorphisms in the human alkyltransferase gene have been identified but the significance of these in terms of alkyltransferase action is currently unknown.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The MGMT, DUSP22, CDCA2, ID2, TNFRSF1B, ZNF681, and IGSF21 may have a role in the etiology and pathogenesis of this disease.[31][32][33][34][35][36][37][38][39][40]”
From Altered genome-wide methylation in endometriosis (2014) · cites this paper as [32]
Citations
Cites
Esteller, M., Hamilton, S. R., Burger, P. C., Baylin, S. B., & Herman, J. G. (1999) · PubMed · Cited by 1,253
Pegg, A. E. (1990) · PubMed · Cited by 734
Self-citationREGULATION AND EXPRESSION OF THE ADAPTIVE RESPONSE TO ALKYLATING AGENTS
Lindahl, T. L., Sedgwick, B., Sekiguchi, M., & Nakabeppu, Y. (1988) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.57.070188.001025 · Cited by 650
Structure, Function, and Inhibition of O6-Alkylguanine-DNA Alkyltransferase
Pegg, A. E., Dolan, M. E., & Moschel, R. C. (1995) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(08)60879-x · Cited by 506
Self-citationParikh, S. S., Mol, C. D., Slupphaug, G., Bharati, S., Krokan, H. E., & Tainer, J. A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5214 · Cited by 497
Roberts, R. J., & Cheng, X. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.181 · Cited by 315
Jaeckle, K. A., Eyre, H. J., Townsend, J. J., Schulman, S., Knudson, H. M., Belanich, M., Yarosh, D. B., Bearman, S., Giroux, D. J., & Schold, S. C. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.10.3310 · Cited by 297
Involvement of the Mismatch Repair System in Temozolomide-Induced Apoptosis
D’Atri, S., Tentori, L., Lacal, P. M., Graziani, G., Pagani, E., Benincasa, E., Zambruno, G., Bonmassar, E., & Jiricny, J. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.2.334 · Cited by 282
Repair of DNA containing O 6 ‐alkylguanine
Pegg, A. E., & Byers, T. L. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.6.1544541 · Cited by 244
Self-citationSrivenugopal, K. S., Yuan, X., Friedman, H. S., & Ali‐Osman, F. (1996) · Biochemistry · doi:10.1021/bi9518205 · Cited by 218
Qian, X. C., & Brent, T. P. (1997) · PubMed · Cited by 214
Watts, G. S., Pieper, R. O., Costello, J., Peng, Y.-M., Dalton, W. S., & Futscher, B. W. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5612 · Cited by 214
Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma.
Friedman, H. S., Kokkinakis, D. M., Pluda, J. M., Friedman, A. H., Cokgor, I., Haglund, M. M., Ashley, D. M., Rich, J. N., Dolan, M. E., Pegg, A. E., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.11.3570 · Cited by 213
Self-citationO6-benzylguanine and its role in chemotherapy.
Dolan, M. E., & Pegg, A. E. (1997) · PubMed · Cited by 211
Self-citationKaina, B., Ziouta, A., Ochs, K., & Coquerelle, T. M. (1997) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(97)00187-5 · Cited by 197
Moore, M. H., Gulbis, J. M., Dodson, E. J., Demple, B., & Moody, P. C. E. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06410.x · Cited by 194
Msh2 status modulates both apoptosis and mutation frequency in the murine small intestine
Toft, N. J., Winton, D. J., Kelly, J., Howard, L., Dekker, M., Riele, H. T., Arends, M. J., Wyllie, A. H., Margison, G. P., & Clarke, A. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3911 · Cited by 168
Regulation of Repair of Alkylation Damage in Mammalian Genomes
MITRA, S. P., & Kaina, B. (1993) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(08)60218-4 · Cited by 165
p53 expression and risk factors for cutaneous melanoma: A case-control study
Whiteman, D. C., Parsons, P. G., & Green, A. C. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980911)77:6 · Cited by 154
O6-alkylguanine DNA lesions trigger apoptosis
Meikrantz, W. (1998) · Carcinogenesis · doi:10.1093/carcin/19.2.369 · Cited by 147
Silber, J. R., Bobola, M. S., Ghatan, S., Blank, A., Kolstoe, D. D., & Berger, M. S. (1998) · PubMed · Cited by 144
Grombacher, T., Eichhorn, U., & Kaina, B. (1998) · Oncogene · doi:10.1038/sj.onc.1202000 · Cited by 142
Silber, J. R., Blank, A., Bobola, M. S., Ghatan, S., Kolstoe, D. D., & Berger, M. S. (1999) · PubMed · Cited by 135
Zaidi, N. H., Pretlow, T. P., O’Riordan, M. A., Dumenco, L. L., Allay, E. R., & Gerson, S. L. (1995) · Carcinogenesis · doi:10.1093/carcin/16.3.451 · Cited by 133
Kawate, H., Sakumi, K., Tsuzuki, T., Nakatsuru, Y., Ishikawa, T., Takahashi, S., Takano, H., Noda, T., & Sekiguchi, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5116 · Cited by 132
Methylnitrosourea-induced tumorigenesis in MGMT gene knockout mice.
Sakumi, K., Shiraishi, A., Shimizu, S., Tsuzuki, T., Ishikawa, T., & Sekiguchi, M. (1997) · PubMed · Cited by 131
Chen, W., Dong, Z., Valcic, S., Timmermann, B. N., & Bowden, G. T. (1999) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199902)24:2 · Cited by 131
Spiro, T. P., Gerson, S. L., Liu, L., Majka, S. M., Haaga, J. R., Hoppel, C. L., Ingalls, S. T., Pluda, J. M., & Willson, J. K. V. (1999) · PubMed · Cited by 126
Davis, B. M., Reese, J., Koç, O. N., Lee, K., Schupp, J. E., & Gerson, S. L. (1997) · PubMed · Cited by 114
Wang, L., Spratt, T. E., Liu, X.-K., Hecht, S. S., Pegg, A. E., & Peterson, L. A. (1997) · Chemical Research in Toxicology · doi:10.1021/tx9602067 · Cited by 108
Self-citationGenomic instability and tolerance to alkylating agents.
Karran, P., & Hampson, R. (1996) · PubMed · Cited by 108
Siemiatycki, J., Fritschi, L., Nadon, L., & Gérin, M. (1997) · American Journal of Industrial Medicine · doi:10.1002/(sici)1097-0274(199703)31:3 · Cited by 106
Tominaga, Y. (1997) · Carcinogenesis · doi:10.1093/carcin/18.5.889 · Cited by 98
Wild-type p53 suppresses transcription of the human O6-methylguanine-DNA methyltransferase gene.
Harris, L. C., Remack, J. S., Houghton, P. J., & Brent, T. P. (1996) · PubMed · Cited by 95
Xu‐Welliver, M., Kanugula, S., & Pegg, A. E. (1998) · PubMed · Cited by 94
Self-citationHigh incidence of nitrosamine-induced tumorigenesis in mice lacking DNA repair methyltransferase
Iwakuma, T. (1997) · Carcinogenesis · doi:10.1093/carcin/18.8.1631 · Cited by 93
Boldogh, I. R., Ramana, C. V., Chen, Z., Biswas, T., Hazra, T. K., Grösch, S., Grombacher, T., MITRA, S. P., & Kaina, B. (1998) · PubMed · Cited by 92
Becker, K., Dösch, J., Gregel, C. M., Martin, B. A., & Kaina, B. (1996) · PubMed · Cited by 89
Middleton, M. R., Lunn, J., Morris, C., Rustin, G. J. S., Wedge, S. R., Brampton, M., Lind, M., Lee, S. M., Newell, D. R., Bleehen, N. M., et al. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.654 · Cited by 86
DNA alkylation repair limits spontaneous base substitution mutations in Escherichia coli
Mackay, W. J., Han, S., & Samson, L. D. (1994) · Journal of Bacteriology · doi:10.1128/jb.176.11.3224-3230.1994 · Cited by 83
O6-benzylguanine in humans: metabolic, pharmacokinetic, and pharmacodynamic findings.
Dolan, M. E., Roy, S. K., Fasanmade, A. A., Paras, P. R., Schilsky, R. L., & Ratain, M. J. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.5.1803 · Cited by 82
Rafferty, J. A., Clarke, A. R., Sellappan, D., Santibanez‐Koref, M., Frayling, I. M., & Margison, G. P. (1996) · PubMed · Cited by 82
Silber, J. R., Blank, A., Bobola, M. S., Mueller, B. A., Kolstoe, D. D., Ojemann, G. A., & Berger, M. S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.6941 · Cited by 79
Liu, L. (1999) · Carcinogenesis · doi:10.1093/carcin/20.2.279 · Cited by 77
DNA alterations in cancer : genetic and epigenetic changes
Ehrlich, M. (2000) · Medical Entomology and Zoology · Cited by 76
N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosourea sensitivity in mismatch repair-defective human cells.
Aquilina, G., Ceccotti, S., Martinelli, S., Hampson, R., & Bignami, M. (1998) · PubMed · Cited by 74
Activation of human O6-methylguanine-DNA methyltransferase gene by glucocorticoid hormone
Biswas, T., Ramana, C. V., Srinivasan, G., Boldogh, I. R., Hazra, T. K., Chen, Z., Tano, K., Thompson, E. B., & MITRA, S. P. (1999) · Oncogene · doi:10.1038/sj.onc.1202320 · Cited by 73
Understanding and manipulating O6-methylguanine-DNA methyltransferase expression
Pieper, R. O. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)00003-x · Cited by 69
Лукаш, Л. Л., Boldt, J., Pegg, A. E., Dolan, M. E., Maher, V. M., & McCormick, J. J. (1991) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(91)90196-u · Cited by 68
Self-citationHampson, R., Humbert, O., Macpherson, P., Aquilina, G., & Karran, P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28596 · Cited by 68
McElhinney, R. S., Donnelly, D. J., McCormick, J. E., Kelly, J., Watson, A. J., Rafferty, J. A., Elder, R. H., Middleton, M. R., Willington, M. A., McMurry, T. B. H., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9708644 · Cited by 67
Imal, Y., Oda, H., Nakatsuru, Y., & Ishikawa, T. (1995) · Carcinogenesis · doi:10.1093/carcin/16.10.2441 · Cited by 66
Hazra, T. K., Roy, R., Biswas, T., Grabowski, D. T., Pegg, A. E., & MITRA, S. P. (1997) · Biochemistry · doi:10.1021/bi963085i · Cited by 66
Self-citationMismatch repair and differential sensitivity of mouse and human cells to methylating agents
Humbert, O. (1999) · Carcinogenesis · doi:10.1093/carcin/20.2.205 · Cited by 61
Koç, O. N., Reese, J., Davis, B. M., Liu, L., Majczenko, K. J., & Gerson, S. L. (1999) · Human Gene Therapy · doi:10.1089/10430349950018418 · Cited by 60
Goodtzova, K., Kanugula, S., Edara, S., Pauly, G. T., Moschel, R. C., & Pegg, A. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.13.8332 · Cited by 59
Self-citationArmstrong, M. J., & Galloway, S. M. (1997) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(96)00234-5 · Cited by 58
Wedge, S. R., Porteous, J. K., & Newlands, E. S. (1997) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050657 · Cited by 57
Tentori, L., Orlando, L., Lacal, P. M., Benincasa, E., Faraoni, I., Bonmassar, E., D’Atri, S., & Graziani, G. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.2.249 · Cited by 57
Kanugula, S., Goodtzova, K., Edara, S., & Pegg, A. E. (1995) · Biochemistry · doi:10.1021/bi00021a024 · Cited by 54
Self-citationInhibition of DNA repair as a means of increasing the antitumor activity of DNA reactive agents
Dolan, M. E. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00028-8 · Cited by 54
Genetic polymorphism of human O6-alkylguanine-DNA alkyltransferase
Deng, C., Xie, D., Capasso, H., Zhao, Y., Wang, L., & Hong, J. (1999) · Pharmacogenetics · doi:10.1097/00008571-199902000-00011 · Cited by 54
Crone, T. M., Goodtzova, K., & Pegg, A. E. (1996) · Mutation Research/DNA Repair · doi:10.1016/0921-8777(95)00058-5 · Cited by 53
Self-citationModulation of cyclophosphamide activity by O ? 6 -alkylguanine-DNA alkyltransferase
Johnson, S. P., Loktionova, N. A., Dolan, M. E., Modrich, P. L., Struck, R. F., Brent, T. P., Ludeman, S. M., Keir, S., Dong, Q. D., Colvin, O. M., et al. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050866 · Cited by 53
Self-citationMammalian DNA repair methyltransferases shield O4MeT from nucleotide excision repair
Samson, L. D. (1997) · Carcinogenesis · doi:10.1093/carcin/18.5.919 · Cited by 53
DNA-repair methyltransferase as a molecular device for preventing mutation and cancer
Sekiguchi, M., Nakabeppu, Y., Sakumi, K., & Tuzuki, T. (1996) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01209646 · Cited by 51
Pegg, A. E., Swenn, K., Chae, M.-Y., Dolan, M. E., & Moschel, R. C. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00249-y · Cited by 46
Self-citationChinnasamy, N., Rafferty, J. A., Hickson, I., Lashford, L. S., Longhurst, S. J., Thatcher, N., Margison, G. P., Dexter, T. M., & Fairbairn, L. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300699 · Cited by 46
Critical steps in alkylation-induced aberration formation
Kaina, B. (1998) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(98)00103-1 · Cited by 46
Reese, J., Davis, B. M., Liu, L., & Gerson, S. L. (1999) · PubMed · Cited by 46
Becker, K., Gregel, C. M., & Kaina, B. (1997) · PubMed · Cited by 45
Engelbergs, J., Thomale, J., Galhoff, A., & Rajewsky, M. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1635 · Cited by 45
Novel human DNA alkyltransferases obtained by random substitution and genetic selection in bacteria.
Christians, F. C., & Loeb, L. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.6124 · Cited by 44
Kanai, T., Konno, H., Tanaka, T., Matsumoto, K., Baba, M., Nakamura, S., & Baba, S. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970529)71:5 · Cited by 41
Mattern, J. (1998) · Carcinogenesis · doi:10.1093/carcin/19.7.1247 · Cited by 40
Chen, F. Y., Harris, L. C., Remack, J. S., & Brent, T. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4348 · Cited by 39
Creation of a Fully Functional Human Chimeric DNA Repair Protein
Hansen, W. K., Deutsch, W. A., Yacoub, A., Xu, Y., Williams, D. A., & Kelley, M. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.2.756 · Cited by 38
Treatment of human brain tumor xenografts with O6-benzyl-2'-deoxyguanosine and BCNU.
Schold, S. C., Kokkinakis, D. M., Rudy, J. L., Moschel, R. C., & Pegg, A. E. (1996) · PubMed · Cited by 38
Self-citationSpratt, T. E., Wu, J. D., Levy, D. E., Kanugula, S., & Pegg, A. E. (1999) · Biochemistry · doi:10.1021/bi982908w · Cited by 38
Self-citationChen, Z. P., Yarosh, D. B., Garcia, Y., Tampieri, D. I., Mohr, G., Malapetsa, A., Langleben, A., & Panasci, L. (1999) · PubMed · Cited by 38
Loktionova, N. A., & Pegg, A. E. (1996) · PubMed · Cited by 37
Self-citationLim, A., & Li, B. F. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00778.x · Cited by 36
Ali, R. B., Teo, A. K.-C., Oh, H.-K., Chuang, L. S.-H., Ayi, T.-C., & Li, B. F. L. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.3.1660 · Cited by 36
Bender, K. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.11.2087 · Cited by 35
Oh, H.-K., Teo, A. K.-C., Ali, R. B., Lim, A., Ayi, T.-C., Yarosh, D. B., & Li, B. F. L. (1996) · Biochemistry · doi:10.1021/bi9603635 · Cited by 35
Goodtzova, K., Kanugula, S., Edara, S., & Pegg, A. E. (1998) · Biochemistry · doi:10.1021/bi9811718 · Cited by 35
Self-citationKanugula, S., Goodtzova, K., & PEGG, E. A. (1998) · Biochemical Journal · doi:10.1042/bj3290545 · Cited by 35
McLendon, R. E., Cleveland, L., Pegram, C. N., Bigner, S. H., Bigner, D. D., & Friedman, H. S. (1998) · PubMed · Cited by 34
Maze, R., Kapur, R., Kelley, M. R., Hansen, W. K., Oh, S.-J., & Williams, D. A. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.2.1006 · Cited by 33
Engineering human DNA alkyltransferases for gene therapy using random sequence mutagenesis.
Encell, L. P., Coates, M. M., & Loeb, L. A. (1998) · PubMed · Cited by 33
Greenwood, S. K., Armstrong, M. J., Hill, R., Bradt, C. I., Johnson, T. E., Hilliard, C. A., & Galloway, S. M. (1998) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(97)00272-8 · Cited by 33
Edara, S., Kanugula, S., & Pegg, A. E. (1999) · Carcinogenesis · doi:10.1093/carcin/20.1.103 · Cited by 33
Self-citationCreation of human alkyltransferases resistant to O6-benzylguanine.
Christians, F. C., Dawson, B. J., Coates, M. M., & Loeb, L. A. (1997) · PubMed · Cited by 33
Pauly, G. T. (1998) · Carcinogenesis · doi:10.1093/carcin/19.3.457 · Cited by 33
Polymorphism in the human O6-methylguanine-DNA methyltransferase gene detected by PCR-SSCP analysis
Otsuka, M., Abe, M., Nakabeppu, Y., Sekiguchi, M., & Suzuki, T. (1996) · Pharmacogenetics · doi:10.1097/00008571-199608000-00010 · Cited by 32
Loktionova, N. A., Xu‐Welliver, M., Crone, T. M., Kanugula, S., & Pegg, A. E. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00095-7 · Cited by 31
Self-citationLiem, L.-K., Lim, A., & Li, B. F. L. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.9.1613 · Cited by 31
Mouse methyltransferase for repair of O6-methylguanine and O4-methylthymine in DNA
Kawate, H., Ihara, K., Kohda, K., Sakumi, K., & Sekiguchi, M. (1995) · Carcinogenesis · doi:10.1093/carcin/16.7.1595 · Cited by 30
Wang, L., Spratt, T. E., Pegg, A. E., & Peterson, L. A. (1999) · Chemical Research in Toxicology · doi:10.1021/tx980251+ · Cited by 29
Self-citationBCNU is a caspase-mediated inhibitor of drug-induced apoptosis.
Peták, I., Mihalik, R., Bauer, P. I., Süli‐Vargha, H., Sebestyén, A. R., & Kopper, L. (1998) · PubMed · Cited by 28
Nickel(II) inhibits the repair of O 6 -methylguanine in mammalian cells
Iwitzki, F., Schlepegrell, R., Eichhorn, U., Kaina, B., Beyersmann, D., & Hartwig, A. (1998) · Archives of Toxicology · doi:10.1007/s002040050561 · Cited by 28
Kooistra, R. A., Zonneveld, J. B. M., Lohman, P. H. M., Pastink, A., Watson, A. J., & Margison, G. P. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.8.1795 · Cited by 27
A new model for how O6-methylguanine-DNA methyltransferase binds DNA.
Vora, R. A., Pegg, A. E., & Ealick, S. E. (1998) · PubMed · Cited by 26
Self-citationTerashima, I., & Kohda, K. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970363i · Cited by 26
Xu‐Welliver, M., & Pegg, A. E. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3470519 · Cited by 26
Self-citationTentori, L., Lacal, P. M., Benincasa, E., Franco, D., Faraoni, I., Bonmassar, E., & Graziani, G. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37448-8 · Cited by 26
Xu‐Welliver, M., Leitão, J. M., Kanugula, S., Meehan, W. J., & Pegg, A. E. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00216-6 · Cited by 25
Self-citationXu‐Welliver, M., Leitão, J., Kanugula, S., & Pegg, A. E. (1999) · PubMed · Cited by 24
Self-citationKurpad, S. N., Dolan, M. E., McLendon, R. E., Archer, G. E., Moschel, R. C., Pegg, A. E., Bigner, D. D., & Friedman, H. S. (1997) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050577 · Cited by 24
Self-citationPegg, A. E., Kanugula, S., Edara, S., Pauly, G. T., Moschel, R. C., & Goodtzova, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.18.10863 · Cited by 24
Self-citationMaze, R., Kurpad, C., Pegg, A. E., Erickson, L. C., & Williams, D. A. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35054-2 · Cited by 24
Self-citationMh, W., Ke, L., Oi, O., Kokkinakis, D. M., Hs, F., & Me, D. (1999) · PubMed · Cited by 23
Allay, E. R., Reese, J., McGuire, E. A., Koç, O. N., Sedransk, N., & Gerson, S. L. (1997) · Oncogene · doi:10.1038/sj.onc.1201384 · Cited by 23
Phillips, W. P., Willson, J. K. V., Markowitz, S. D., Zborowska, E., Zaidi, N. H., Liu, L.-Z., Gordon, N. H., & Gerson, S. L. (1997) · PubMed · Cited by 22
Nagane, M., Asai, A., Shibui, S., Nomura, K., & Kuchino, Y. (1997) · Neurosurgery · doi:10.1097/00006123-199708000-00021 · Cited by 22
Suzuki, M., Sugimoto, Y., & Tsuruo, T. (1998) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(98)00002-5 · Cited by 22
Case, M. C., Burt, A. D., Hughes, J., Palmer, J. M., Collier, J. D., Bassendine, M. F., Yeaman, S. J., Hughes, M. A., & Major, G. N. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(98)00207-5 · Cited by 20
Keir, S. T., Dolan, M. E., Pegg, A. E., Lawless, A., Moschel, R. C., Bigner, D. D., & Friedman, H. S. (2000) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800051016 · Cited by 19
Self-citationPaalman, S. R., Sung, C., & Clarke, N. D. (1997) · Biochemistry · doi:10.1021/bi970740t · Cited by 19
Inefficient Repair of RNA · DNA Hybrids
Kamath‐Loeb, A. S., Hizi, A., Tabone, J. C., Solomon, M. S., & Loeb, L. A. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.0492a.x · Cited by 19
Liu, L., Lee, K. H., Wasan, E. K., & Gerson, S. L. (1996) · PubMed · Cited by 18
Pletsa, V. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00262-6 · Cited by 18
Repair of DNA lesion O 6 -methylguanine in hepatocellular carcinogenesis
Major, G. N., & Collier, J. D. (1998) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s005340050059 · Cited by 17
Roles of DNA repair methyltransferase in mutagenesis and carcinogenesis
Sekiguchi, M., & Sakumi, K. (1997) · The Japanese Journal of Human Genetics · doi:10.1007/bf02766939 · Cited by 17
Citti, L., Eckstein, F., Capecchi, B., Mariani, L., Nevischi, S., Poggi, A. D., & Rainaldi, G. (1999) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1999.9.125 · Cited by 17
Xu‐Welliver, M., Kanugula, S., Loktionova, N. A., Crone, T. M., & Pegg, A. E. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3470527 · Cited by 17
Self-citationPegg, A. E., Chung, L., & Moschel, R. C. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00060-9 · Cited by 17
Self-citationMounetou, E., Débiton, E., Buchdahl, C., Gardette, D., Gramain, J., Maurizis, J., Veyre, A., & Madelmont, J. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm960881d · Cited by 16
Major, G. N., BRADY, M., Notarianni, G., Collier, J. D., & Douglas, M. S. (1997) · Biochemical Society Transactions · doi:10.1042/bst025359s · Cited by 16
Nutt, C. L., Loktionova, N. A., Pegg, A. E., Chambers, A. F., & Cairncross, J. G. (1999) · Carcinogenesis · doi:10.1093/carcin/20.12.2361 · Cited by 15
Self-citationExpression of the O6-alkylguanine-DNA alkyltransferase gene is elevated in human breast tumor cells.
Wani, G., & Sm, D. (1998) · PubMed · Cited by 15
Potentiation of BCNU antitumor efficacy by 9-substituted O 6-benzylguanines. Effect of metabolism
Kokkinakis, D. M., Moschel, R. C., Pegg, A. E., & Schold, S. C. (2000) · Cancer Chemotherapy and Pharmacology · doi:10.1007/pl00006746 · Cited by 14
Self-citationSchlink, K., Janssen, K., Nitzsche, S., Gebhard, S., Hengstler, J. G., Klein, S., & Oesch, F. (1999) · Archives of Toxicology · doi:10.1007/s002040050581 · Cited by 14
Tano, K., Dunn, W. C., Darroudi, F., Shiota, S., Preston, R. J., Natarajan, A. T., & MITRA, S. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.20.13250 · Cited by 13
Kleibl, K., & Margison, G. P. (1998) · PubMed · Cited by 12
Dolan, M. E., Roy, S. K., Garbiras, B. J., Helft, P. R., Paras, P. R., Chae, M.-Y., Moschel, R. C., & Pegg, A. E. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00047-1 · Cited by 12
Self-citationOrganization and Expression of the Mouse Gene for DNA Repair Methyltransferase
Iwakuma, T., SHIRAISHI, A., FUKUHARA, M., Kawate, H., & Sekiguchi, M. (1996) · DNA and Cell Biology · doi:10.1089/dna.1996.15.863 · Cited by 11
Terashima, I., Kawate, H., Sakumi, K., Sekiguchi, M., & Kohda, K. (1997) · Chemical Research in Toxicology · doi:10.1021/tx9700580 · Cited by 11
Citti, L., Boldrini, L., Preuss, I., Kaina, B., Mariani, L., & Rainaldi, G. (1996) · Carcinogenesis · doi:10.1093/carcin/17.1.25 · Cited by 9
Gerson, S. L., Schupp, J., Liu, L., Pegg, A. E., & Srinivasen, S. (1999) · PubMed · Cited by 8
Self-citationFederwisch, M., Hassiepen, U., Bender, K., Dewor, M., Rajewsky, M. F., & Wollmer, A. (1997) · Biochemical Journal · doi:10.1042/bj3240321 · Cited by 8
Melanoma-cell toxicity of cystemustine combined with O6-benzyl-N2-acetylguanosine
Buchdahl, C., Rolhion, C., Glasser, A.-L., Débiton, E., Mounetou, E., Madelmont, J., & Laval, F. (1998) · Melanoma Research · doi:10.1097/00008390-199804000-00004 · Cited by 7
O6-Alkylguanine-DNA alkyltransferase in normal colon tissue and colon cancer.
White, A., Kibitel, J. T., Garcia, Y., Belanich, M., Yarosh, D. B., Wideroff, J., Levin, L., Held, D., Fuchs, A., & Citron, M. L. (1997) · PubMed · Cited by 7
First partial three-dimensional model of human monoamine oxidase A
Wouters, J., & Baudoux, G. (1998) · Proteins Structure Function and Bioinformatics · doi:10.1002/(sici)1097-0134(19980701)32:1 · Cited by 7
Self-citation
Research works printed but not linked: 6
- Kaur, 1999, Role of the O6-alkylguanine DNA alkyltransferase codons 143 and 160 polymorphisms in lung cancer risk, Proc. Am. Assoc. Cancer Res., 40, A1646
- Egyhazi, 1999, Novel polymorphisms in the O6-methylguanine DNA methyltransferase gene in human melanoma, Proc. Am. Assoc. Cancer Res., 40, A3093
- Crone, 1999, Ubiquitin-mediated proteolysis of O6-alkylguanine-DNA alkyltransferase following inactivation with O6-benzylguanine, Proc. Am. Assoc. Cancer Res., 40, A2656
- Herfath, 1999, A specific CpG methylation pattern of the MGMT promoter region associated with reduced MGMT expression in primary colorectal cancers, Mol. Carcinog., 24, 90, 10.1002/(SICI)1098-2744(199902)24:2<90::AID-MC3>3.0.CO;2-B · DOI
- Middleton, 1999, O6-(4-Bromothenyl)-guanine is an effective inactivator of O6-alkylguanine-DNA alkyltransferase, and improves the therapeutic index of temozolomide to a greater extent than O6-benzylguanine, Proc. Am. Assoc. Cancer Res., 40, A39
- Friedman, 1999, The biology of sensitivity and resistance to the molecule (temozolomide), Proc. Am. Assoc. Cancer Res., 40, 754
Cited by
Sorted by citations
Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality
Sletten, E. M., & Bertozzi, C. R. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200900942 · Cited by 3,165
A general method for the covalent labeling of fusion proteins with small molecules in vivo
Keppler, A., Gendreizig, S., Gronemeyer, T., Pick, H. M., Vogel, H., & Johnsson, K. (2002) · Nature Biotechnology · doi:10.1038/nbt765 · Cited by 1,964
Genetic Pathways to Primary and Secondary Glioblastoma
Ohgaki, H., & Kleihues, P. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070011 · Cited by 1,487
“Various adducts at this position are substrates for repair by MGMT.(82) Such adducts typically result from exposure to N-nitrosamides and related alkylating agents that cause brain tumors in rats,(83) but there is currently no evidence indicating that alkylating carcinogens are involved in the etiology of human brain…”
BackgroundOhgaki, H., & Kleihues, P. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.6.479 · Cited by 1,382
“DNA methylation may be caused by N-nitroso compounds in food or tobacco (21, 64), and through nonenzymatic methylation by S-adenosylmethionine (SAM) (65).”
BackgroundInfluentialMGMT: its role in cancer aetiology and cancer therapeutics
Gerson, S. L. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1319 · Cited by 817
“AGT repairs O 6 -AG in both open chromatin during transcription and replication, and in resting, condensed DN”
Background
Metadata
- Authors
- Pegg, A. E.
- Affiliations
- Pennsylvania State University (US)
- Corresponding author
- Pegg, Anthony E
- Venue
- Mutation Research/Reviews in Mutation Research
- Publisher
- Elsevier BV
- Published
- 2000-04
- Volume
- 462
- Issue
- 2-3
- Pages
- 83-100
- ISSN
- 1383-5742 (ISSN-L)
- OpenAlex
- W1999549596
- Cited by
- 576
- References
- 167
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 16 · 2023: 12 · 2022: 11 · 2021: 10 · 2020: 15 · 2019: 17 · 2018: 13 · 2017: 14 · 2016: 16 · 2015: 21 · 2014: 30 · 2013: 36 · 2012: 26
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Mutation Research/Reviews in Mutation Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA57725, CA-18137, R01CA071976, CA 71976)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- O6-alkylguanine, alkyltransferase, DNA repair, O6-methylguanine, O6-benzylguanine, alkylating agents, ubiquitin-proteasome degradation, promoter methylation, gene silencing, p53, temozolomide resistance, transgenic mice, myelosuppression
- MeSH terms
- Animals, DNA Repair, Guanine, Humans, DNA Adducts, Alkyl and Aryl Transferases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review